This report contains market size and forecasts of Chronic Idiopathic Constipation Drugs in global, including the following market information:
Global Chronic Idiopathic Constipation Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Chronic Idiopathic Constipation Drugs Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Chronic Idiopathic Constipation Drugs companies in 2021 (%)
The global Chronic Idiopathic Constipation Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Linaclotide Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Chronic Idiopathic Constipation Drugs include Pfizer, Glaxosmithkline, Roche Holding AG, Sanofi, Bayer AG, Merck, Eli Lilly, Allergens and Chugai Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Chronic Idiopathic Constipation Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Chronic Idiopathic Constipation Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Chronic Idiopathic Constipation Drugs Market Segment Percentages, by Type, 2021 (%)
Linaclotide
Lubiprostone
Others
Global Chronic Idiopathic Constipation Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Chronic Idiopathic Constipation Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Chronic Idiopathic Constipation Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Chronic Idiopathic Constipation Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Chronic Idiopathic Constipation Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Chronic Idiopathic Constipation Drugs revenues share in global market, 2021 (%)
Key companies Chronic Idiopathic Constipation Drugs sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Chronic Idiopathic Constipation Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Glaxosmithkline
Roche Holding AG
Sanofi
Bayer AG
Merck
Eli Lilly
Allergens
Chugai Pharmaceutical
Ferring International Center S.A
Synergy Pharmaceuticals
Salix Pharmaceuticals Ltd
Sucampo Pharmaceuticals Inc
Ironwood Pharmaceuticals Inc
Bausch Health
Daiichi Sankyo
Cosmo Pharmaceuticals SA
Progenics Pharmaceuticals Inc
Theravance Biopharma Inc